Data too important to share: do those who control the data control the message?
dc.contributor.author | Doshi, Peter | |
dc.date.accessioned | 2017-05-25T01:13:45Z | |
dc.date.available | 2017-05-25T01:13:45Z | |
dc.date.issued | 2016-03-02 | |
dc.identifier.citation | Doshi, P. (2016). Data too important to share: do those who control the data control the message? BMJ 2016;352:i1027. DOI: https://doi.org/10.1136/bmj.i1027 | en_US |
dc.identifier.uri | http://hdl.handle.net/10713/6602 | |
dc.description | Hydroxyethyl starch solutions for fluid resuscitation fell from grace in 2013 after European and American regulators issued severe warnings about their safety. But the academic investigators that led a landmark trial that helped precipitate this downfall are refusing to share their data. Is this acceptable? Peter Doshi reports. | en_US |
dc.description.uri | http://bmj.com/cgi/content/full/bmj.i1027?ijkey=4AnYoyKyRdrYVzf&keytype=ref | |
dc.language.iso | en_US | en_US |
dc.publisher | BMJ Publishing Group | en_US |
dc.subject | data sharing | en_US |
dc.subject | research transparency | en_US |
dc.subject.mesh | Information Dissemination--ethics | en_US |
dc.subject.mesh | Hydroxyethyl Starch Derivatives | en_US |
dc.subject.mesh | Hemorrhage--therapy | en_US |
dc.subject.mesh | Clinical Trials as Topic | en_US |
dc.title | Data too important to share: do those who control the data control the message? | en_US |
dc.type | Article | en_US |
dc.identifier.doi | doi.org/10.1136/bmj.i1027 | |
dc.identifier.pmid | 26936297 | |
dc.description.uriname | Click here for the free full-text article on publisher's website | en_US |
refterms.dateFOA | 2019-02-19T18:15:10Z |